Quality of Life After Bariatric Surgery

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04524429

Enrollment

300

Registered

2020-08-24

Start date

2020-06-23

Completion date

2021-02-01

Last updated

2020-08-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bariatric Surgery Candidate, Obesity, Obesity, Morbid, Quality of Life

Brief summary

This study aims to assess long term outcomes for patients who have underwent bariatric surgery. In particular, it aims to assess the quality of life of these participants.

Interventions

PROCEDUREBariatric Surgery

Bariatric surgery includes sleeve gastrectomy and gastric bypass.

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Obese, either received bariatric surgery or have been referred for bariatric surgery.

Exclusion criteria

* Emergency cases, Obese patients who have not been referred for bariatric surgery.

Design outcomes

Primary

Measure	Time frame	Description
Quality of life before and after bariatric surgery	This represents the patients current quality of life within the last 4 weeks.	Difference in SF-36 between post-bariatric surgical patients and representative pre-operative patients who have not undergone bariatric surgery (quality of life).

Secondary

Measure	Time frame	Description
Current Weight	This is the patients current weight within the last 4 weeks	This represents the patients current weight in kilograms.
Lowest Weight	Retrospectively reviewed on average of 5 years	This represents the patients lowest weight after bariatric surgery
Change in marker of Type 2 Diabetes Mellitus	Preoperative use compared to results within the last 4 weeks	Using HbA1C scores and use of insulin
Change in marker of OSA	Preoperative use compared with use in the last 4 weeks	Use of CPAP
Change in marker of hyperlipidemia	Preoperative use compared with use in the last 4 weeks	Number of medications used to manage condition
Change in marker of GORD	Preoperative use compared with use in the last 4 weeks	Number of medications used to manage condition
Change in marker of hypertension	Preoperative use compared with use in the last 4 weeks	Number of medications used to manage condition

Countries

Australia

Contacts

Primary ContactAntonio Barbaro, MBBS

antonio.barbaro@sa.gov.au8222 6000

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026